Sign inGet started

GRASSO MARC

Insider CIK 1748894 · KURA CFO, CBO · ALEC Chief Financial Officer · KYTX Chief Financial Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
KYTX Kyverna Therapeutics, Inc. A Award deriv2026-03-132026-03-1765,000— $065,000SEC↗
KYTX Kyverna Therapeutics, Inc. A Award2026-03-132026-03-1710,000— $010,000SEC↗
KYTX Kyverna Therapeutics, Inc. A Award deriv2025-06-302025-07-01450,000— $0450,000SEC↗
ALEC Alector, Inc. S Sale2025-06-022025-06-0416,488$1.34 $22.1K296,072SEC↗
ALEC Alector, Inc. S Sale2025-03-032025-03-0518,091$1.47 $26.6K312,560SEC↗
ALEC Alector, Inc. S Sale2024-12-022024-12-0316,489$2.52 $41.6K330,651SEC↗
ALEC Alector, Inc. A Award2024-10-012024-10-02216,400— $0347,140SEC↗
ALEC Alector, Inc. S Sale2024-09-032024-09-047,297$4.88 $35.6K130,740SEC↗
ALEC Alector, Inc. S Sale2024-06-032024-06-046,920$4.80 $33.2K138,037SEC↗
ALEC Alector, Inc. S Sale2024-03-042024-03-055,716$6.92 $39.6K144,957SEC↗
ALEC Alector, Inc. S Sale2023-12-042023-12-064,574$5.56 $25.4K150,673SEC↗
ALEC Alector, Inc. A Award deriv2023-10-012023-10-0341,000— $041,000SEC↗
ALEC Alector, Inc. A Award2023-10-012023-10-03123,000— $0155,247SEC↗
ALEC Alector, Inc. S Sale2023-09-052023-09-061,114$5.19 $5.8K32,247SEC↗
ALEC Alector, Inc. S Sale2023-06-022023-06-051,050$6.90 $7.2K33,361SEC↗
ALEC Alector, Inc. S Sale2023-03-022023-03-031,291$8.32 $10.7K34,411SEC↗
ALEC Alector, Inc. A Award deriv2022-10-012022-10-0423,801— $023,801SEC↗
ALEC Alector, Inc. A Award2022-10-012022-10-0435,702— $035,702SEC↗
ALEC Alector, Inc. A Award deriv2022-03-012022-03-03450,000— $0450,000SEC↗
KURA Kura Oncology, Inc. A Award deriv2022-01-262022-01-28131,000— $0131,000SEC↗
KURA Kura Oncology, Inc. A Award2022-01-262022-01-2821,900— $021,900SEC↗
KURA Kura Oncology, Inc. A Award deriv2021-01-262021-01-28175,000— $0175,000SEC↗
KURA Kura Oncology, Inc. M Exercise deriv2020-09-142020-09-157,898— $0105,000SEC↗
KURA Kura Oncology, Inc. M Exercise deriv2020-09-142020-09-152,102— $0247,898SEC↗
KURA Kura Oncology, Inc. M Exercise2020-09-142020-09-152,102$29.00 $61.0K10,000SEC↗
KURA Kura Oncology, Inc. S Sale2020-09-142020-09-1510,000$29.00 $290.0K0SEC↗
KURA Kura Oncology, Inc. M Exercise2020-09-142020-09-157,898$29.00 $229.0K7,898SEC↗
KURA Kura Oncology, Inc. M Exercise deriv2020-09-082020-09-1010,000— $0112,898SEC↗
KURA Kura Oncology, Inc. M Exercise2020-09-082020-09-1010,000$15.47 $154.7K10,000SEC↗
KURA Kura Oncology, Inc. S Sale2020-09-082020-09-1010,000$26.00 $260.0K0SEC↗
KURA Kura Oncology, Inc. M Exercise deriv2020-08-252020-08-2610,000— $0122,898SEC↗
KURA Kura Oncology, Inc. S Sale2020-08-252020-08-2610,000$23.00 $230.0K0SEC↗
KURA Kura Oncology, Inc. M Exercise2020-08-252020-08-2610,000$15.47 $154.7K10,000SEC↗
KURA Kura Oncology, Inc. M Exercise deriv2020-08-072020-08-117,102— $0132,898SEC↗
KURA Kura Oncology, Inc. S Sale2020-08-072020-08-1110,000$20.00 $200.0K0SEC↗
KURA Kura Oncology, Inc. M Exercise2020-08-072020-08-117,102$15.47 $109.9K10,000SEC↗
KURA Kura Oncology, Inc. A Award deriv2020-01-302020-02-03111,723— $0111,723SEC↗
KURA Kura Oncology, Inc. A Award deriv2019-01-222019-01-24140,000— $0140,000SEC↗
KURA Kura Oncology, Inc. A Award deriv2018-08-212018-08-22250,000— $0250,000SEC↗